Key | % Net Assets |
---|---|
Reynolds American | 3.5% |
Roche | 3.1% |
Vodafone | 3.0% |
Koninklijke KPN | 2.9% |
Other | 87.5% |
Name | % Net Assets |
---|---|
Reynolds American | 3.5% |
Roche | 3.1% |
Vodafone | 3.0% |
Koninklijke KPN | 2.9% |
Philip Morris International | 2.8% |
Novartis | 2.8% |
Johnson & Johnson | 2.7% |
Jardine Matheson | 2.1% |
National Grid | 2.1% |
Hewlett Packard | 2.0% |
No asset data available.
Date | 21-Nov-2024 |
---|---|
NAV | 293.56p |
Currency | GBP |
Change | 0.37p |
% | 0.13% |
YTD change | 33.96p |
YTD % | 13.08% |
Fund Inception | 02/03/2009 |
---|---|
Fund Manager | n/a |
TER | 1.69 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.67% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research